Enhancing the apoptotic and therapeutic effects of HDAC inhibitors
Ailsa J Frew, Ricky W Johnstone, Jessica E Bolden
Cancer Letters | ELSEVIER IRELAND LTD | Published : 2009
We apologise to those whose work was not cited or discussed due to space limitations. We thank members of the Johnstone laboratory for helpful discussions. Ricky Johnstone is a Pfizer Australia Research Fellow and is supported by the National Health and Medical Research Council of Australia, the Cancer Council Victoria, the Leukaemia Foundation of Australia and by research grants from Novartis and Merck. Ailsa Frew and Jessica Bolden are supported by The Cancer Research Institute Predoctoral Emphasis Pathway in Tumor Immunology.